Epigral (EPIGRAL)₹890.25−2.51%Specialty Chemicals
At the end of the Jun 2026 quarter, Epigral's shareholders were: promoters 68.84%, FIIs 1.02%, DIIs 5.61%, government 0.02%, public 24.51%. Promoter holding is unchanged on the quarter. FII holding is down 2.01 percentage points from 3.03% a year earlier. 0.00% of promoter shares were pledged. It had 76,319 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 71.39% | 71.39% | 71.50% | 71.59% | 71.59% | 68.95% | 68.96% | 68.84% | 68.84% | 68.84% | 68.84% | 68.84% |
| FIIs | 1.13% | 1.16% | 1.35% | 1.45% | 2.08% | 2.98% | 2.98% | 3.03% | 2.68% | 2.34% | 1.53% | 1.02% |
| DIIs | 0.04% | 0.05% | 0.02% | 0.18% | 1.18% | 4.35% | 4.70% | 4.82% | 4.98% | 5.18% | 4.95% | 5.61% |
| Government | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
| Public | 27.42% | 27.38% | 27.11% | 26.76% | 25.13% | 23.70% | 23.34% | 23.29% | 23.48% | 23.62% | 24.66% | 24.51% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 95,760 | 92,976 | 88,887 | 85,777 | 83,192 | 81,712 | 80,893 | 79,966 | 78,620 | 77,577 | 77,598 | 76,319 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Ashishbhai Natawarlal Soparkar | Promoter | 14.66% | 0.00 |
| Patel Natwarlal Meghjibhai | Promoter | 9.69% | 0.00 |
| Jayantibhai Meghjibhai Patel | Promoter | 8.23% | 0.00 |
| Rameshbhai Meghjibhai Patel | Promoter | 6.77% | 0.00 |
| Maulik Jayantibhai Patel | Promoter | 5.15% | 0.00 |
| Patel Ankit Natwarlal | Promoter | 4.46% | 0.00 |
| Anandbhai Ishwarbhai Patel | Promoter | 4.17% | 0.00 |
| Bandhan Small Cap Fund | DII | 2.96% | +0.64 |
| HSBC Mutual Fund - HSBC Value Fund | DII | 2.55% | −0.03 |
| Taraben Jayantilal Patel | Promoter | 2.35% | 0.00 |
| VLS Finance Ltd | Public | 1.90% | 0.00 |
| Patel Karana Rameshbhai | Promoter | 1.69% | 0.00 |
| Patel Kalpana Rameshbhai | Promoter | 1.27% | 0.00 |
| Disha Kevatkumar Vanani | Promoter | 1.14% | 0.00 |
| Patel Natubhai Meghjibhai (HUF) | Promoter | 1.12% | 0.00 |
| Bhartiben Natubhai Patel | Promoter | 0.97% | 0.00 |
| Vaishakhi Dhiren Goyal | Promoter | 0.97% | 0.00 |
| Chintan Anandbhai Patel | Promoter | 0.95% | 0.00 |
| Patel Darshan Anandbhai | Promoter | 0.95% | 0.00 |
| Kruti Adesh Patel | Promoter | 0.86% | 0.00 |
| Nayanaben A Soparkar | Promoter | 0.77% | 0.00 |
| Deval A Soparkar | Promoter | 0.46% | 0.00 |
| Ruchi Ashishbhai Soparkar | Promoter | 0.46% | 0.00 |
| Patel Naynaben Anandbhai | Promoter | 0.39% | 0.00 |
| Patel Rameshbhai Meghjibhai(HUF) | Promoter | 0.22% | 0.00 |
Promoters held 68.84% of Epigral at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 1.02% (down 0.51 percentage points from 1.53% a quarter earlier) and domestic institutions (DIIs) held 5.61% (up 0.66 percentage points from 4.95% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Epigral had 76,319 shareholders at the end of the Jun 2026 quarter, against 79,966 a year earlier.
Bandhan Small Cap Fund (DII) held 2.96% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.